Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1682
This examiner grants 0% of resolved cases
Christine Michelle Jones is an examiner in Tech Center 1600 and Art Unit 1634. The profile shows 1 resolved cases and an allowance rate of 0.0 percent. The total number of resolved cases establishes the reliability of the prosecution data. This specific percentage helps practitioners estimate the likelihood of an application reaching an allowance.
The interview lift is also 0.0 percent. This figure shows the difference in allowance probability when an interview is conducted. Practitioners can use this metric to evaluate the utility of direct communication with the examiner during prosecution. This value serves as a guide for deciding whether to request a formal discussion.
The median days to allowance is 1067. This period represents the middle value of the time taken to reach an allowance. With 1 resolved cases, the 1067-day duration characterizes the experience for applications assigned to this examiner. Practitioners should plan for this timeline when seeking a grant in Art Unit 1634.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18634263 | SEQUENCING BY SYNTHESIS USING ELECTROACTIVELY LABELED 3-OH-MODIFIED NUCLEOTIDES | Non-Final OA | Robert Bosch GmbH |
| 18561259 | Next-Generation Volumetric in Situ Sequencing | Final Rejection | The Board of Trustees of the Leland Stanford Junior University |
| 18546472 | CELL-FREE DNA METHYLATION TEST | Non-Final OA | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 18565775 | METHOD FOR PROVIDING RARE SUGAR ASSIMILATION ABILITY DETERMINING GENE CLUSTER OF RARE SUGAR NON-METABOLIC STRAIN | Non-Final OA | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 18279769 | METHODS AND DEVICES FOR NUCLEIC ACID DETECTION | Final Rejection | The Regents of the University of Colorado, a Body Corporate |
| 18506858 | METHODS AND COMPOSITIONS FOR COPY-NUMBER INFORMED TISSUE-OF-ORIGIN ANALYSIS | Final Rejection | GUARDANT HEALTH, INC. |
| 18423804 | Methods, Systems, and Compositions for Diagnosing Transplant Rejection | Non-Final OA | The Scripps Research Institute |
| 18692623 | DETECTION OF TARGET NUCLEIC ACID SEQUENCE BY USING SYNTHETIC NON-NATURAL BASE-BEARING TAG OLIGONUCLEOTIDE | Non-Final OA | SEEGENE, INC. |
| 18534113 | FLOW CELLS AND SEQUENCING KITS | Final Rejection | ILLUMINA, INC. |
| 17281809 | Prostate Cancer Biomarker Assays | Final Rejection | Kingston Health Sciences Centre |
| 17495652 | PROGRAMMABLE NUCLEASE IMPROVEMENTS AND COMPOSITIONS AND METHODS FOR NUCLEIC ACID AMPLIFICATION AND DETECTION | Final Rejection | MAMMOTH BIOSCIENCES, INC. |
| 17576972 | LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) ANALYSIS FOR PATHOGENIC TARGETS | Non-Final OA | Raytheon BBN Technologies, Corp. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy